InMode Announces Collaboration with Cure Medical and Appointment of Adam Bashir as Managing Director
InMode UK today announced a strategic business collaboration with Cure Medical, alongside the appointment of Adam Bashir as Managing Director of InMode UK, marking an important milestone in the company’s continued growth in the UK & Irish medical aesthetics market.
The UK and Irish medical aesthetics industry continues to grow rapidly, with increasing demand from doctors and clinics for comprehensive, high-quality, energy-based device solutions delivered through a single trusted partner. InMode UK is strengthening its commercial and leadership management to better serve practitioners across the country.
Cure Medical is a medical aesthetics company with an exclusive portfolio of innovative international topical and device products providing advanced aesthetic skin solutions.
The company is led by Adam Bashir, who brings over 20 years of experience in the UK & Irish Aesthetic Industry working across marketing and sales of energy-based devices to doctors and aesthetic professionals. With a wealth of experience, Bashir has been responsible for the successful launch and market penetration of brands such as ALMA across the UK & Ireland.
Through this business collaboration, InMode UK and Cure Medical will align their marketing and sales activities, operating as a unified commercial team in the UK. By combining complementary strengths, the collaboration delivers a broader, more comprehensive portfolio of medical aesthetic technologies, supported by experienced management and a strong commercial organisation .
As part of this next phase, Mr Adam Bashir has been appointed Managing Director of InMode UK, where he will lead the company’s commercial strategy, drive growth, and further strengthen partnerships with surgeons, doctors, dentists, medical practitioners and clinics throughout the UK.
Mr.Moshe Mizrahy, InMode CEO shares; “This collaboration represents an important step in strengthening our position in the UK, By combining InMode UK’s established presence with Cure Medical’s commercial expertise and Adam’s leadership, we are creating strong synergies that will support our customers and partners long term.”
Adam Bashir, Managing Director of InMode UK, commented: "With InMode UK poised for the next phase of growth together with the complimentary portfolio of Cure Medical advanced skin solutions, I am excited as it is very timely for the commercial collaboration in order to achieve critical mass to become the leading company in medical aesthetics in the UK & Ireland."
With this strengthened leadership structure and expanded commercial collaboration, InMode UK enters 2026 in a significantly stronger position. By combining an established global brand, a broader and more comprehensive portfolio of medical aesthetic skin solutions, and an experienced management team, the company is exceptionally well positioned to deliver increased value to its users and to play a leading role in shaping the UK medical aesthetics market.
